Cure Brain Cancer Foundation recently launched its first ever Global Ambassador Program, including an Oscar-winning filmmaker and an international financial adviser, ahead of World Cancer Research Day on Friday 24 September.
Cure Brain Cancer CEO Lance Kawaguchi said the Program was designed to collaborate globally to amplify awareness of the realities of brain cancer, create change and inspire others.
“Our Global Ambassadors support the vision for the Foundation – a cure for brain cancer, and actively demonstrate the Foundation’s values of Respect, Integrity, Accountability, and Innovation in driving our message across the globe to build ongoing support for the Foundation,” Mr Kawaguchi said.
“I am honoured to launch the Foundation’s first ever Global Ambassador Program, including our first two phenomenal Ambassadors, Nick Reed and Elizabeth Dillon.
“Nick is an Oscar winning filmmaker and founder of Shareability, the world’s first StoryTech Company that combines Oscar level storytelling and Silicon Valley technology to break through the noise and build explosive growth for brands. He has worked with celebrities and major brands from Rihanna to Ford and will support the Foundation to create powerful digital content that raises awareness for brain cancer and Cure Brain Cancer Foundation.
“Elizabeth Dillon is the Head of USA for Pictet Asset Management and has a personal connection to the cause, sadly losing her mother to the disease. Elizabeth is an entrepreneur, leader and innovator. Her strong global network and commitment to promoting the Foundation’s vision will help us forge global connections to find a cure for brain cancer as quickly as possible,” Mr Kawaguchi said.
World Cancer Research Day, held on September 24 annually, highlights the importance of research in slowing the progression of the disease and further improving survival rates and quality of life for those affected.
“Cure Brain Cancer Foundation has invested more than $21 million into priority driven research. “Our strategy aims to get new treatments to patients faster by injecting funds across the entire research pathway. We want to ensure every person diagnosed with brain cancer in Australia has access to a quality clinical trial.”
Original story found on the Third Sector and the Cure Brain Cancer Foundation websites respectively. Note: Content has been edited for style and length.
Join our mailing list to be on the front lines of healthcare , get exclusive content, and promos.